The effects of metformin on lipid-induced atherosclerosis.
D000818:Animals; D001158:Arteries / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D004036:Diet, Atherogenic; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005234:Fatty Liver / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D007408:Intestinal Absorption / Q000187:drug effects; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D010629:Phenformin / Q000627:therapeutic use*; D010743:Phospholipids / Q000378:metabolism; D011817:Rabbits
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D010743:Phospholipids; D006003:Glycogen; D008687:Metformin; D002784:Cholesterol; D010629:Phenformin